相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting proteasome ubiquitin receptor Rpn13 in multiple myeloma
Y. Song et al.
LEUKEMIA (2016)
Targeting PD1-PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells
A. Ray et al.
LEUKEMIA (2015)
POH1 deubiquitylates and stabilizes E2F1 to promote tumour formation
Boshi Wang et al.
NATURE COMMUNICATIONS (2015)
A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance
Ze Tian et al.
BLOOD (2014)
Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study
Paul G. Richardson et al.
BLOOD (2014)
A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma
Paul G. Richardson et al.
BLOOD (2014)
Regulated protein turnover: snapshots of the proteasome in action
Sucharita Bhattacharyya et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
In Vitro and In Vivo Antitumor Activity of a Novel Alkylating Agent, Melphalan-Flufenamide, against Multiple Myeloma Cells
Dharminder Chauhan et al.
CLINICAL CANCER RESEARCH (2013)
Deubiquitinating Enzymes as Therapeutic Targets in Cancer
Key-Hwan Lim et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Functions of the 19S complex in proteasomal degradation
Chang-Wei Liu et al.
TRENDS IN BIOCHEMICAL SCIENCES (2013)
A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance
Dharminder Chauhan et al.
CANCER CELL (2012)
Molecular architecture of the 26S proteasome holocomplex determined by an integrative approach
Keren Lasker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Inhibition of proteasome deubiquitinating activity as a new cancer therapy
Padraig D'Arcy et al.
NATURE MEDICINE (2011)
Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
Paul G. Richardson et al.
BLOOD (2010)
Recognition and Processing of Ubiquitin-Protein Conjugates by the Proteasome
Daniel Finley
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
Functional Interaction of Plasmacytoid Dendritic Cells with Multiple Myeloma Cells: A Therapeutic Target
Dharminder Chauhan et al.
CANCER CELL (2009)
DUBs and cancer The role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors
Sajjad Hussain et al.
CELL CYCLE (2009)
Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple Myeloma
Paul G. Richardson et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Relative structural and functional roles of multiple deubiquitylating proteins associated with mammalian 26S proteasome
Elena Koulich et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myelorna
Deborah J. Kuhn et al.
BLOOD (2007)
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome
Herve Avet-Loiseau et al.
BLOOD (2007)
The JAMM motif of human deubiquitinase Poh1 is essential for cell viability
Melissa Gallery et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Endoplasmic reticulum stress compromises the ubiquitin-proteasome system
V Menéndez-Benito et al.
HUMAN MOLECULAR GENETICS (2005)
Molecular pathogenesis and a consequent classification of multiple myeloma
PL Bergsagel et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The ubiquitin of its roles in system for protein degradation and some the control of the cell-division cycle - (Nobel Lecture)
A Hershko
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
The proteasome: A suitable antineoplastic target
J Adams
NATURE REVIEWS CANCER (2004)
Participation of the proteasomal lid subunit Rpn11 in mitochondrial morphology and function is mapped to a distinct C-terminal domain
T Rinaldi et al.
BIOCHEMICAL JOURNAL (2004)
Ubiquitin: structures, functions, mechanisms
CM Pickart et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2004)
Protein degradation and protection against misfolded or damaged proteins
AL Goldberg
NATURE (2003)
Characterization of the MM.1 human multiple myeloma (MM) cell lines: A model system to elucidate the characteristics, behavior, and signaling of steroid-sensitive and -resistant MM cells
S Greenstein et al.
EXPERIMENTAL HEMATOLOGY (2003)
Changes in expression of the human homologue of the Drosophila discs large tumour suppressor protein in high-grade premalignant cervical neoplasias
RA Watson et al.
CARCINOGENESIS (2002)
Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome
R Verma et al.
SCIENCE (2002)
A cryptic protease couples deubiquitination and degradation by the proteasome
TT Yao et al.
NATURE (2002)
Mitochondrial effects of the pleiotropic proteasomal mutation mpr1/rpn11:: uncoupling from cell cycle defects in extragenic revertants
T Rinaldi et al.
GENE (2002)
A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14
A Borodovsky et al.
EMBO JOURNAL (2001)
Characterization of a novel human cell-cycle-regulated homologue of Drosophila dlg1
S Bassal et al.
GENOMICS (2001)
分享论文
